Today: 30 April 2026
Browse Category

NASDAQ:LGCB 16 October 2025

Linkage Global (LGCB) Stock Doubles on Funding Lifeline – Can the E-Commerce Underdog Sustain the Rally?

Linkage Global (LGCB) Stock Doubles on Funding Lifeline – Can the E-Commerce Underdog Sustain the Rally?

Linkage Global Inc. (NASDAQ: LGCB) shares surged nearly 90% overnight, hitting $3.16 in pre-market trading on Oct. 16 after closing at $1.65. The rally follows news of fresh funding deals, including a facility to sell up to $100 million in stock pending shareholder approval. Despite the spike, the stock remains down 34% over the past month. Revenue fell 27% in H1 2025, while net loss widened to $3.09 million.
16 October 2025
··

Stock Market Today

  • S&P 500 Gains on Mixed Mega-Cap Earnings; Dow Leads with Caterpillar Surge
    April 30, 2026, 3:16 PM EDT. The U.S. stock market showed mixed gains Thursday. The Dow Jones Industrial Average led with a 1.3% rise, fueled by Caterpillar's 10% jump after strong earnings tied to AI-related construction demand. The S&P 500 rose 0.4%, and the Nasdaq-100 edged 0.2%, shaped by mixed mega-cap earnings. Alphabet jumped over 9% after Google's Cloud unit reported 63% revenue growth and revealed a large $462 billion backlog in cloud orders. Meta and Microsoft shares fell over 5% amid concerns about their rising artificial intelligence (AI) infrastructure spending, despite beating analyst estimates. Nvidia slipped 4.3% without earnings, pressured by Alphabet shipping AI accelerators to limited customers, signaling growing competition. Oil prices steadied after regional tensions eased. Overall, investors navigated headwinds from AI spending costs against robust earnings growth.

Latest article

Option Care Health Stock Plunges After 2026 Revenue Cut Exposes Chronic-Therapy Drag

Option Care Health Stock Plunges After 2026 Revenue Cut Exposes Chronic-Therapy Drag

30 April 2026
Option Care Health shares fell 28% to $19.44 after the company cut its 2026 revenue forecast and reported first-quarter sales of $1.35 billion, missing estimates. The company now expects 2026 revenue of $5.675–$5.775 billion, down from a prior range of $5.8–$6.0 billion, citing pressure in its chronic inflammatory disease portfolio. Adjusted profit guidance was unchanged.
Stellantis N.V. Stock Slides: Q1 Profit Rebound Leaves One Big Cash-Flow Question

Stellantis N.V. Stock Slides: Q1 Profit Rebound Leaves One Big Cash-Flow Question

30 April 2026
Stellantis reported a first-quarter net profit of €377 million, reversing a €387 million loss a year earlier, aided by a €400 million expected U.S. tariff refund. Industrial free cash flow remained negative at €1.92 billion. Shares fell 6.4% to €6.22 after the results. CEO Antonio Filosa faces pressure ahead of a May 21 investor day to present a stronger turnaround plan.
Go toTop